Home/Filings/4/0001104659-21-078408
4//SEC Filing

Deflin Gayle 4

Accession 0001104659-21-078408

CIK 0001297184other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 8:51 PM ET

Size

6.9 KB

Accession

0001104659-21-078408

Insider Transaction Report

Form 4
Period: 2021-06-07
Deflin Gayle
Director
Transactions
  • Award

    Common Stock

    2021-06-07+6,0196,019 total
  • Award

    Stock Option (right to buy)

    2021-06-07+17,18217,182 total
    Exercise: $19.52Exp: 2029-06-07Common Stock (17,182 underlying)
Footnotes (2)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 7, 2022.
  • [F2]All of the shares subject to the option vest on June 7, 2022.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001866024

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 8:51 PM ET
Size
6.9 KB